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Abstract
This chapter aims to explain the key parameters of analytical method develop-
ment using the chromatography techniques which are used for the identification, 
separation, purification, and quantitative estimation of complex mixtures of 
organic compounds. Mainly, the versatile techniques of ultra−/high-performance 
liquid chromatography (UPLC/HPLC) are in use for the analysis of assay and 
organic impurities/related substances/degradation products of a drug substance 
or drug product or intermediate or raw material of pharmaceuticals. A suitable 
analytical method is developed only after evaluating the major and critical separa-
tion parameters of chromatography (examples for UPLC/HPLC are selection of 
diluent, wavelength, detector, stationary phase, column temperature, flow rate, 
solvent system, elution mode, and injection volume, etc.). The analytical method 
development is a process of proving the developed analytical method is suitable 
for its intended use for the quantitative estimation of the targeted analyte present 
in pharmaceutical drugs. And it mostly plays a vital role in the development and 
manufacture of pharmaceuticals drugs.
Keywords: analytical method development, ultra performance liquid 
chromatography (UPLC), high-performance liquid chromatography (HPLC), assay, 
impurities, impurity profiling study, forced degradation study
1. Introduction
It is well known that chromatography is a laboratory technique used for separation 
and quantification of complex organic mixtures which cannot be separated effectively 
by other purification techniques. The constituents of a mixture dissolved in solvent 
get separated gradiently according to their affinities to the stationary phase with 
the help of mobile phase one after another. Chromatography is invented by Mikhail 
Semenovich Tswett in 1903 during his research on plant pigments such as chlorophylls, 
xanthophylls, and carotenoids [1] which got extended for analyzing organic mol-
ecules of different kinds especially pharmaceutical from the year 1920 [2]. Invention 
of chromatography made the jobs of organic chemist and the whole industry relying 
on them especially pharma industry easier. Keeping in mind the various fields where 
this technique has been used, this chapter focuses on the use of chromatography in 
pharmaceuticals for separating the drug (API) mixture in particular.
Nowadays, many different kinds of chromatography techniques, such as thin-
layer chromatography (TLC), paper chromatography, and liquid chromatography 
(e.g., HPLC, UPLC, and preparative HPLC), supercritical fluid chromatography, 
and gas chromatography (GC)) have been designed and utilized for the separation 
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and purification of pharmaceutical drugs [3]. In this chapter, the authors discuss 
the principles for chromatography method development using ultra/high-perfor-
mance liquid chromatography (UPLC/HPLC) techniques for the analysis of assay 
and organic impurities/related substances/degradation products of pharmaceuticals 
(any drug product/drug substance/intermediate/raw material of pharmaceuticals). 
These techniques are developed substantially as a result of the work of Archer John 
Porter Martin and Richard Laurence Millington Synge during the 1940s and 1950s, for 
which they won the 1952 Nobel Prize in Chemistry [4]. Commonly used character-
izing technique in pharma industry is liquid chromatography (e.g., HPLC, UPLC, 
and LC–MS). Each one varies in the stationary phase and operational conditions. 
HPLC and UPLC can be used as a quantitative technique if coupled with a mass 
detector (MS) to elucidate the structure of the molecule and quantification.
In pharma industry specific, stability-indicating HPLC/UPLC methods have to 
be developed to estimate the assay and to quantitatively determine the impurities of 
new drug substances and drug products [5]. Assay is a quantitative test of a sub-
stance to determine the amount of an individual components present in it. Impurity 
is an unknown component of drug substance that is not the chemical entity. Assay 
and impurity tests are major and critical quality attributes of the pharmaceutical 
dosage forms which help to check and ensure the quality, safety, and efficacy of 
drug substances and drug products. This chapter will discuss the various param-
eters that have to be chosen to run the chromatography in order to have a better 
separation and maximum purity. The process of changing the conditions in order 
to design a best method run for a particular drug mixture or compound is called the 
analytical method development.
2. Analytical method development
Analytical method development is a process of proving that the developed 
chromatography method is suitable for its intended use in the development and 
manufacturing of the pharmaceutical drug substance and drug product. The basic 
separation techniques and principles involved in the analytical method develop-
ment using the HPLC and UPLC are listed as follows:
• Selection of chromatography mode
• Selection of detector
• Selection of column (stationary phase)
• Selection and optimization of mobile phase
 ○ Buffer and its strength
 ○ pH of buffer
 ○ Mobile-phase composition
• Selection of organic modifiers
• Selection of ion-pair reagents
• Selection of flow rate
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• Selection of solvent delivery system (elution mode)
• Selection of diluent
• Methods of extraction
• Samples to be used
• Experimentation to finalize the method
• Selection of test concentration and injection volume
• Forced degradation studies (stress resting)
• Evaluation of stress testing
• Mass balance study
• Finalization of wavelengths
• Stability of solution
• System suitability
• Robustness of the method
• Relative response factor
• Quantification methods
2.1 Literature search
i. Before starting an analytical method development, literature on some of the 
column characteristics as mentioned below has to be referred for the target 
molecules or similar molecules or precursors from open resources like articles, 
books, pharmacopeia reports, etc. This will give a tentative choice in designing 
a method for initial or test experiments, which will be further modified or 
updated to develop a method which fits the separation process for better results 
in terms of reproducibility, quantification, etc. Solubility profile of drug sub-
stance in different solvents at different pH conditions is useful while selecting 
the diluents for standard solutions and extraction solvents for test solutions.
ii. Analytical profile is useful in understanding the physicochemical proper-
ties (e.g., pKa, melting point, degradation pathways, etc.) and absorption 
characteristics of drug in selecting the detector wavelength for analysis.
iii. Stability profile of the drug substance with respect to storage conditions 
(sensitivity of the drug towards light, heat, moisture etc.) is useful as it helps 
in adopting the suitable/adequate precautions while handling drug and its 
formulated products.
iv. Impurity profile collects the information of impurities and degradation 
profile of the drug substance during their formation pathways. This helps 
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a lot in developing the method for separation of all possible impurities and 
degradation products of targeted analyte. It should be borne in mind that 
impurity profile may vary depending on the manufacturing process (which 
uses different methods, precursors, and conditions), which makes it clear 
that not all manufacturing processes yield the same impurity profile.
v. Metabolic pathway is a chemical reaction which occurs within a cell when the 
drug molecule reacts with an enzyme and forms a metabolite [6]. Metabolic 
pathway gives the information on oxidation, reduction, and hydrolysis 
products which gives critical inputs on the possible degradation products.
vi. Stability-indicating method is to identify the closely related structures by 
collecting the structures of the molecule and its impurities and degradation 
products. This helps to develop a specific and stability-indication method 
with a good resolution between the closely related structures.
vii. Checking the polarity of the drug molecule using the functional groups as 
elucidated from structural analysis techniques. By comparing the structures 
of impurities and degradation products with the structure of drug molecule, 
it will help in understanding the polarity based on the nature of functional 
groups. This makes the scientists’ job easy in choosing the right solvents with 
either lesser or higher in polarity than the compound of interest.
viii. Estimation of maximum daily dose (MDD). Calculate the reporting, identi-
fication, and qualification thresholds of drug substance and drug product 
based on the maximum daily dose as per ICH Q3A guideline [7, 8]. MDD info 
can also be obtained from physical desk reference (PDR), innovator product 
information leaflet (PIL), and the website of RX-list (www.rxlist.com).
2.2 Selection of chromatography mode
Chromatography can be operated by two ways, normal mode and reverse phase 
modes. The choice of the mode is very important, which is dependent on the type of 
sample which has to be separated. In general, the usage of reversed-phase chro-
matography (in which the mobile phase is polar and stationary phase is nonpolar 
in nature) is the preferred mode for most of the molecules, except in the case of 
isomer (enantiomers) separation where the normal-phase chromatography (in 
which the mobile phase is nonpolar and stationary phase is polar in nature) is used. 
Revered-phase chromatography separates the components with a good resolution 
based on their hydrophobicity. A compound with a greater polarity elutes earlier, 
and those with the least polarity elute later.
2.3 Selection of detector
Detector plays an important role in the finalization of any analytical method. 
Generally most of the organic/drug molecules are aromatic or unsaturated in 
nature, which has an absorption in the UV–vis region. This comes as an advantage 
in quantifying and analyzing the molecules and its associated impurities. The 
absorbance maxima of the compound shall be collected by analyzing the UV–vis 
spectrophotometer or diode array detector (DAD) of HPLC/UPLC. From the area 
intensity of the test compound using calibration curves, the quantification of the 
test compound can be done [9–10].
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If the compounds do not absorb and if they do not have chromophores, other 
detectors like refractive index detector (RID) and evaporative light scattering detec-
tor (ELSD)/corona-charged aerosol detector (CAD) can be used for the quantitative 
determination of assay and impurities [11]. If the compounds of interest contain a 
part, which is non-chromophoric, which may likely be cleaved and produce a non-
chromophoric impurity, then both UV and other detectors like RI/ELSD/CAD can 
be coupled in order not to miss any impurity.
Alternatively, non-chromophoric compounds can also be analyzed by UV 
after converting it into a derivative which will be active. But the usage of deriva-
tives has to be carefully assessed keeping in view the functional group involved 
in the derivatization reaction [12, 13]. In case the molecule of interest is having 
fluorescence properties, a fluorescence detector (FLD) can be used for com-
pounds for which structural information is available [14]. But when FLD is to 
be used for estimation of unknowns, it needs to be carefully assessed whether 
fluorescence properties are available in all possible impurities and  
degradation products.
2.4 Selection of column stationary phase
The choice of the right column (stationary phase) is the basis of the whole 
technology. Most chromatographic separations are achieved due to a wide variety 
of columns available in the market and due to their flexibility in changing and 
controlling the parameters. A widely used choice of column material is silica 
either as neat or modified depending on the nature of the solute mixture in 
normal-phase chromatography, wherein the eluent (mobile phase) is nonpolar 
an organic solvent. The silanol groups on the surface of the silica give it a polar 
character.
Though silica remains the most common support for liquid chromatography 
(LC) columns, other commonly used materials are cross-linked organic poly-
mers, zirconia, etc. The silica support for columns was gradually modified for 
the betterment through the years by three different manufacturing technolo-
gies commonly described as “evolution through three generations.” The initial 
process started with type A silica where the raw material used is from inorganic 
sols. A slightly modified type A silica by performing a chemical treatment to 
remove the metal impurities is termed as a second-generation material which is 
called as base-deactivated silica. Third generation silica (type B) is an altogether 
new process which uses organic sols instead of inorganic sols. These materials 
are similar in properties to the second-generation silica because both have a 
minimum level of metal impurities. Silica-based liquid chromatography columns 
with a different percent of cross-linking and functionalization of silanol groups 
with substituted aliphatic and aromatic moieties were designed for varying 
polarities of the separating medium. An increasing order of functionalized  
silica is represented below with alkyl groups at the nonpolar end, phenyl and 
amino functionalized in the moderate polar region, and cyano and silica groups 
at the polar end.
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The following are the parameters of a chromatographic column which need to 
be considered while choosing a column (stationary phase) for separation of assay, 
impurities, and degradation products:
i. Length and diameter of column
ii. Packing material
iii. Shape of particles
iv. Size of particles
v. Percent (%) of carbon loading
Column dimension: Length and internal diameter of packing bed.
• Short (30–50 mm)—can result in short run times and low back pressure
• Long (250–300 mm)—can result in higher-resolution and long run times
A column with a diameter of 2.1 mm leads to a high resolution.
Particle size: Decrease in particle size leads to increase in resolution but with a 
corresponding increase in back pressure. In general smaller particles offer higher 
efficiency, but there is a chance to get high back pressure limiting the separation 
efficiency. Less (3 μm) particles are usually used for resolving complex and mul-
ticomponent samples, where the lesser surface area induces better resolution and 
separation characteristics.
Pore size and surface area: Larger pores allow larger solute molecules to be 
retained for a longer time through maximum surface area exposure. High surface 
area generally provides greater retention, capacity, and resolution for multicompo-
nent samples. Low surface area materials generally equilibrate quickly and provide 
lesser separation efficiency but can be highly preferred and important in gradient 
analyses.
Carbon loading: Higher carbon loads generally offer greater resolution and 
longer run times. Low carbon loads shorten run times, and many show a different 
selectivity. A pictorial representation of difference in carbon loading is as shown 
below.
End capping: End capping reduces peak tailing of polar compounds that 
interact excessively with the otherwise exposed, mostly acidic silanols. Non-end 
capped packing provides a different selectivity than do end-capped packing, 
especially for polar compounds. A pictorial representation of difference in end 
capping is shown below.
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2.5 Selection and optimization of mobile phase
Though adsorption is the principle behind chromatography, real separation 
happens only when the adsorbed compound is eluted using a mobile phase of the 
required polarity. The selection of mobile phase is done always in combination 
with the selection of column (stationary phase). The following are the param-
eters which shall be taken into consideration while selecting and optimizing the 
mobile phase.
• The right choice of buffer and its eluting efficiency
• pH of the buffer or pH of the mobile phase
• Mobile-phase composition inclusive of binary and tertiary solvent mixture
2.5.1 Buffer and its strength
Buffer and its efficiency play an important role in deciding the peak symme-
tries (shapes) and peak separation. Various types of organic/inorganic buffers are 
employed for achieving the required separation. The most commonly used buffers are:
• Phosphate buffers—KH2PO4, K2HPO4, NaH2PO4, Na2HPO4, H3PO4, etc.
• Acetate buffers—Ammonium acetate, sodium acetate, etc.
• Triethylamine/diethylamine buffers
• Buffers with various ion-pair reagents like tetrabutyl ammonium hydrogen sul-
fate, butane sulfonic acid, hexane sulfonic acid, heptane sulfonic acids, etc.
The choice of buffer is to reduce the tailing factor for each peak separated which 
occurs due to varying ionic strength. The retention time of analyte(s) is delayed and 
got separated well when more concentrated buffer is used [15]. Better separation 
happens when the molarity of buffer used is in the range of 0.05 to 0.20 M. The 
concentration of buffer is chosen by carefully choosing the composition of organic 
mobile phase.
Depending on the need of the chosen mixture of separation, the strength of the 
buffer can be increased or decreased if necessary to achieve the required separa-
tion, and it can be varied between 10 and 20%, and the effect of variation has to be 
studied in detail before using. But it should be ensured that increased or decreased 
buffer strength should not result in precipitation or turbidity either in mobile phase 
during operation or during storage in refrigerator. Before using the chosen buffer 
of specific strength to run a column, test experiments have to be done in optimizing 
the separation to avoid peak tailing, better separation, and reproducibility.
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2.5.2 pH of buffer
pH plays an important role in achieving the chromatographic separations as it 
controls the elution properties by controlling the ionization characteristics. The pH of 
buffer or mobile phase should be selected based on the pKa of analyte or test mixture, 
which is based on the structure of the molecule. Depending on the pKa, drug mole-
cules change retentions, e.g., acids show an increase in retention as the pH is reduced, 
while the base shows a decrease. If the pKa of the compound is high, lower pH or 
acidic mobile phase has to be chosen as it will stop unwanted association with the 
stationary phase. For basic compounds, the use of high pH or basic mobile phase and, 
for neutral compound, neutral mobile phase is highly preferable for better separation.
It is important to maintain the pH of the mobile phase in the range of 2.0 ~ 8.0 as 
most columns do not withstand the pH which is outside this range. This is due to the 
fact that the mostly used silica column gets deactivated at high pH (<2) and at low 
pH (>8) due to cleavage of siloxane linkages. If a pH outside the range of 2.0 ~ 8.0  
is found to be necessary, stationary phase which can withstand the range shall be 
chosen [16–18].
2.5.3 Mobile-phase composition
It is well reported in literature that to achieve better efficiency, binary and ter-
tiary solvent mixtures are used along with other components like buffer and acids 
or bases. The ratio of the organic versus (vs.) aqueous or polar vs. nonpolar solvents 
is varied accordingly to get better separation. This is due to the fact that a fairly large 
amount of selectivity can be achieved by choosing the qualitative and quantitative 
composition of aqueous and organic portions. Experiments shall be conducted with 
mobile phases having buffers of different pH and different organic phases to check 
for the best separations between the impurities. Most chromatographic separations 
can be achieved by choosing the optimum mobile phase composition [18].
2.6 Selection of organic modifiers
Most widely used solvents in reverse-phase chromatography are methanol and 
acetonitrile. Tetrahydrofuran (THF) is also used but to a lesser extent [19, 20]. In 
most of the systems, acetonitrile is used as the default organic modifier because of 
favorable UV transmittance and low viscosity. It is recommended to mix acetonitrile 
with 5–10% of the aqueous solution(s) to avoid the pumping problems associated 
with a higher percent (%) of acetonitrile usage. Methanol is also the second most 
widely used solvent in liquid chromatography, but it gives the back pressure to LC 
column. Though THF has some disadvantages like higher UV absorbance, reactivity 
with oxygen, and slower column equilibration, sometimes it gives very unique selec-
tivity for closely eluting peaks. Intermediate selectivity (if needed for a particular 
sample) can be obtained by blending appropriate amounts of each of these solvents.
Order of polarity: methanol > acetonitrile > ethanol > THF > propanol.
Order of solvent strength: propanol > THF > ethanol > acetonitrile > methanol.
2.7 Selection of ion-pair reagents
Ion pair reagents are necessary as a mobile-phase additive when structurally or 
chemically or polarity wise inseparable closely related compounds are to be sepa-
rated [21, 22]. For example, if a mixture of ionic and nonionic analyte(s) having the 
same polarity and same retention time is required to be separated, start by optimiz-
ing for one of the analytes by adding an ion pair reagent in a mobile phase which 
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reduces or increases the polarity of component and helps in increasing the elution 
time difference. Careful choice of an appropriate ion-pair reagent is required in 
such cases to get the necessary selectivity. A dedicated LC column is used when an 
ion pair reagent (0.0005 M to 0.02 M) is intended to employ for specific analysis, 
but an appropriate cleaning procedure has to be established to enhance the lifetime 
of the column material. Alkyl ammonium salts (tertiary or quaternary) and alkyl 
sulfonate salts are the most useful in the separation of acidic and basic compounds, 
respectively. Sodium perchlorate can also be used for acidic components.
2.8 Selection of flow rate
Separation of mixtures is highly influenced by the flow of mobile phase inside 
the column [23, 24]. The flow rate is highly crucial in having well-separated peaks 
with no tailing. The flow rate of the mobile phase can be optimized based on the 
retention time, column back pressure, and separation of closely eluting adjacent 
peaks or impurities and peak symmetries from the test run. Preferably the flow 
rate is fixed not more than 2.0 mL/minute. The flow which gives the least retention 
times, good peak symmetries, least back pressures, and better separation of adja-
cent peaks/impurities could be the chosen as an optimized flow rate for the analysis.
2.9 Selection of column temperature
Temperature is another criterion which has to be optimized for any sample, 
as the flow rate and the rate of adsorption vary with temperature. It is generally 
believed that with increasing temperature, it can help to improve the resolution 
between the adjacent/closely eluting peaks and peak merging. So a careful choice 
of the temperature is a must which might change the pressure of the column and 
ultimately the elution and resolution [25–28].
Choosing ambient temperature for the analysis is always preferred as it will 
minimize the degradation of the test sample; however, higher temperatures are also 
advisable under unavoidable conditions after confirming the stability of the com-
pound. The temperature range which is usually allowed in liquid chromatography is 
25 and 60°C. Higher temperatures above 60°C are preferred if the peak symmetry is 
not good and to increase the retention time for closely occurring peaks.
2.10 Selection of solvent delivery system (elution mode)
Chromatographic separations with a single eluent (isocratic elution: all the 
constituents of the mobile phase are mixed and pumped together as a single eluent) 
are always preferable. However, the gradient elution is a powerful tool in achieving 
separation between closely eluting compounds or compounds having narrow polar-
ity difference [29–31]. An important feature of the gradient elution mode which 
makes it a powerful tool is that the polarity and ionic strength of the mobile phase 
are changed (increased or decreased) during the run. Experiments using different 
mobile-phase combinations and different gradient programs have to be performed 
prior to achieving better separation.
In a gradient run, two mobile phases which have different compositions of 
polar and nonpolar solvents are premixed using a single pump before introducing 
to the column which is called as low pressure gradient (LPG), and when the mobile 
phases are pumped at different flow rate and mixed in a chamber, then intro-
duced into the column is known as high pressure gradient (HPG). It is better to 
select the gradient run, whether LPG or HPG, while optimizing the chromatog-
raphy method. HPG can be only preferred for use when more than 80% organic 
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phase is pumped. To avoid the pumping problems due to the low viscous solvents 
like acetonitrile in mobile phase, at least 10% aqueous portion could be added to 
the organic phase.
While optimizing the gradient program, it is important to monitor the follow-
ing. Pressure graph is needed to be monitored so as to ensure that the overall system 
pressure will not cross 400 bar or 6000 psi at any point during the run. Flow rate 
has to be physically cross-checked by collecting the output from the detector during 
the run at different time intervals, especially when the gradient is running with 
higher organic-phase composition so as to ensure that there were no pumping prob-
lems during the run when mobile phases of different compositions are pumped. It is 
also important to optimize the program for initialization after each run and before 
going for the next injection. The program for initialization shall be optimized such 
that there shall be no carry-over to the next run and the system stabilizes with initial 
composition before the next injection.
One standard program which can be used for optimizing is discussed below. 
For starting a method development, a solvent gradient system is always preferred. 
Initially, start with a gradient of 50:50 buffer and mobile phase, and change the 
program linearly up to 5:95, and retain the ratio for at least 30 minutes. Then try 
with a gradient of 95:5 and the program linearly changed up to 5: 95, and retain for 
at least 30 minutes. The typical gradient program is as follows:
2.11 Selection of diluent
Diluent is an aqueous solution or a solvent used to dissolve and extract the 
drug moiety for analysis. Select a diluent in which impurities, starting material, 
by-product, intermediates, degradation products, and the analyte are soluble. It is 
advisable to check first in the mobile phase. All the analytes should be completely 
soluble and the solution should be clear [32]. Diluent should be compatible with the 
mobile phase to obtain the good peak shape.
• Selection of diluent based on extraction efficiency and peak shapes: Select the 
diluent for finished dosage forms, in which the analyte should be extracted at 
least 95% for assay and 90% for organic impurities. Calculate the % extraction 
against pure standard compound in the concentration of linear range, (prefer-
ably <1 AU) by diluting the test preparation.
• The peak shapes of all compounds should be good in the selected diluent: 
Select an initial flow rate of 1.0 mL/min or 1.5 mL/min and select column 
temperature as ambient (25–30°C).
Diluent is selected initially based on solubility of the substance. However, the 
finalization of diluent is based on its extraction efficiency, peak symmetries, reso-
lution of impurities, and diluent blank injection interference. Inject the diluent 
blank and test solution spiked with known impurities into the chromatographic 
system, and establish the noninterference of blank in estimation of the drug 
and the effect of diluent on resolution of impurities from drug peak and peak 
symmetry.
2.12 Methods of extraction
General methods followed for extraction are sonication, rotary shaking, or 
seldom both. In some cases where the analyte cannot be extracted by the above 
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procedures, heating can be adapted if the substance is stable and should not pre-
cipitate upon cooling to room temperature [33–34].
2.13 Samples to be used for analysis
• Use mixture of impurities, starting material, by-product, intermediates, and 
degradation products to establish the separations.
• Use the reaction mass/mother liquor/what if study samples for the above study 
if all the impurities samples are not available in the beginning for method 
development.
• Use forced degradation samples, if degradation products are not available in 
the case of drug API.
• Prepare a mixture of known impurities spiked on API at a test concentration of 
about 0.5 or 1.0 mg/mL.
• Prepare a placebo (mixture of excipients to be used in formulation) solution at 
a concentration equivalent to test concentration (of about 0.5 or 1.0 mg/mL) 
for the dose in which higher placebo content is expected.
2.14 Experimentation to finalize the method
Inject individual solution of standard and impurities to confirm the retention 
times. Check for the interference from blank. Check for the interference from 
placebo components in the case of the formulation.
Gradient program will provide an assessment of the elution pattern of polar 
and nonpolar impurities. Also, run an isocratic run with a mobile phase of a buffer 
with a suitable pH and acetonitrile in the ratio of acetonitrile: buffer (90:10) using 
a 250 × 4.6 mm, 5 μm silica column. This will help to know whether any highly 
nonpolar impurities are still un-eluted from the column.
2.15 Selection of test concentration and injection volume
The test concentration and injection volume are generally chosen based upon 
the response of API peak at the selected detector wavelength [35]. However, the 
test concentration shall be finalized after it is proven that drug (API) is completely 
extractable at the selected test concentration. After finalizing the test concentra-
tion and diluent, prepare a test solution, and keep the filtered solution in closed 
condition on a bench top, and check whether the solution has any precipitation or 
turbidity after 24 hours. Generally, the test solution must be clear and should not 
show any turbidity or precipitation.
2.16 Forced degradation studies (stress testing)
It’s a method of subjecting the drug substance or drug product to stress with 
varied strengths of stressing agents to obtain the degradation. The stressed samples 
were analyzed using an LC system equipped with a PDA detector and monitored for 
the separation of degradation products formed under the stressed conditions and 
the peak purity of the analyte peak. The method is considered as stability-indicating 
for the estimation of the drug if it meets the peak purity requirement [36, 37].
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Forced degradation studies are conducted basically to meet the following 
objectives:
• To investigate the likely degradation products; this, in turn, helps to establish 
the degradation pathways and the intrinsic stability of the drug molecule.
• To provide a foundation for developing a suitable stability-indicating method.
• Ensure the force degradation limit of 2–20%.
The major forced degradation studies which are to be carried out are as follows:
a. Thermolytic degradation
This stress testing method studies the degradation that is caused by exposure 
to temperature high enough to induce bond breakage. Solid-state reactions often 
proceed in an autocatalytic pathway involving an induction period (lag), fol-
lowed by a period of rapidly increasing degradation and then slowing down of the 
degradation rate as the compound is consumed. Thus, solid-state reaction kinetics 
will often follow an S-shaped curve when degradation vs. time is plotted. Thus, 
before conducting thermolytic degradation, determine the melting point of the 
compounds of interest. Then, choose a temperature of 70°C for all the drugs for 
which melting point is <100°C, or choose a temperature which is 40°C below the 
melting point.
For the compounds for which melting point is >150°C, stress the samples at 
105°C. Keep the samples directly exposed in the oven for 1 week or until about 
2–20% degradation is achieved, whichever is earlier. Stress the drug substance, 
placebo, and drug product separately. In the case of the multicomponent drug 
products, stress testing of placebo with other actives excluding the one at a time 
shall be performed additionally.
b. Hydrolytic degradation
Drug degradation that involves hydrolysis reaction is called hydrolytic degrada-
tion. Hydrolysis reactions are typically acid or base catalyzed. Acidic, neutral, and 
basic conditions should therefore be employed in order to induce potential hydro-
lytic reactions. As these hydrolytic stress studies are to be conducted in aqueous 
solutions, solubility of the drug molecule of interest in water has to be estimated 
first. Many small molecule drugs are not soluble in water at the concentrations typi-
cally used for analytical evaluations (0.1 to 1 mg/mL); in those cases either a slurry 
or suspension must be used to examine the hydrolytic stability of a compound, or 
a cosolvent must be added to facilitate the dissolution under the conditions of low 
solubility. Two most commonly used cosolvents are acetonitrile and methanol. 
Methanol has the potential of participating in the degradation chemistry which 
has to be used with caution especially under acidic conditions when the compound 
being tested contains a carboxylic acid, ester, or amide.
Acetonitrile is generally regarded as inert solvent and is typically preferable 
to methanol in hydrolytic stress testing studies. However, acetonitrile is not com-
pletely inert and can participate in the degradation reactions, leading to art factual 
degradation results.
The other cosolvents that are recommended for the hydrolytic stress testing 
studies are shown below.
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The hydrolytic degradations (using water/0.1 M HCl/0.1 M NaOH with or with-
out cosolvent) are recommended to be performed at a temperature of about 70°C 
with a reflux condenser installed to avoid the loss of evaporation. Reflux  
until about 2–20% degradation is achieved. Stress the drug substance, placebo,  
and drug product separately. Neutralize the stressed solutions before injection. 
Prepare a stressed solution at a higher concentration than that of test  
concentration. In the case of the multicomponent drug products, stress test-
ing of placebo with other actives excluding the one at a time shall be performed 
additionally.
c. Humidity stress
Stress the samples to 90% humidity for 1 week. Stress the drug substance, 
placebo, and drug product separately. In the case of the multicomponent drug 
products, stress testing of placebo with other actives excluding the one at a time 
shall be performed additionally.
d. Oxidative degradation
Oxidative degradation is one of the most common mechanisms of drug 
degradation. Oxidative drug degradation reactions are typically autoxidative, 
that is, the reaction is radical initiated. Radical initiated reactions start with an 
initiation phase involving the formation of radicals followed by propagation phase 
and eventually a termination phase. Thus, the reaction kinetics will often fol-
low S-shaped curve when the degradation vs. time is plotted and will not follow 
Arrhenius kinetics.
In oxidative stress study, the use of temperature > 30°C is not recommended 
because the reaction rate in solution may reduce at higher temp due to the decrease 
in oxygen content of the solvent. Thus, it is always suggested to perform the 
degradation with 3% hydrogen peroxide at room temperature (25–30°C) with 
constant stirring in the dark. Stress for 24 hours or until about 1–20% degradation 
is achieved or whichever is earlier. Stress the drug substance, placebo, and drug 
product separately.
In the case of the multicomponent drug products, stress testing of placebo with 
other actives excluding the one at a time shall be performed additionally.
e. Photolytic degradation
Photolytic degradation is the degradation that results from exposure to 
UV or visible light. Expose the samples to 3 times to 1.2 million lux-hr visible 
and 200 W-hr/m2 UVA. Stress the drug substance, placebo, and drug product 
separately. In the case of the multicomponent drug products, stress testing 
of placebo with other actives excluding the one at a time shall be performed 
additionally.
Acidic pH Neutral pH Basic pH
Acetonitrile Acetonitrile Acetonitrile
DMSO N-methyl pyrrolidine DMSO
Acetic acid Diglyme
Propionic acid p-Dioxane
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2.17 Evaluation of stress testing
Peak purity can be evaluated for the main peak and the major degradants which 
have the peak heights less than 1 AU. Identify the degradation products by co-
injection, in case of known impurities and have comparable spectra.
If any known impurity is observed to be increased in stress, it can be examined 
properly. If process impurity is found to be increased in stress study, it needs to be 
assessed whether there is any secondary pathway of formation of this impurity via 
some other degradant route.
After conducting these studies, verify the chromatograms, and observe any 
peaks merging with respect to main peak and any critical pairs. If any situations 
were arrived, adjust the mobile-phase compositions, column parameters, etc. and 
conclude the method parameters.
After method finalization, check the method using different detectors (RI/
ELSD/CE/LC–MS), and compare the data with other detectors like UV, fluores-
cence, etc. The UV inactive components can be found with these experiments. 
Identify the mass of major degradant which may be formed greater than 1.0% in 
stress studies, and try to establish the structures.
2.18 Mass balance study
Mass balance is a process of adding together the assay value and levels of deg-
radation products to see how closely these add up to 100% of the initial value. It 
is important to have methods that detect all major degradation products. This is 
generally done by performing the assay of forced degraded samples and assesses the 
mass balance. Mass balance has to be achieved at least up to 95% level. If it is less 
than the required criteria, investigation has to be done and justified. The following 
are some of the reasons for not achieving the mass balance.:
• Degradation products are:
 ○ Not eluted from the LC column
 ○ Not detected by the detector used
 ○ Lost from the ample matrix, due to insolubility, volatility, or  
adsorption losses
 ○ Co-eluted with the parent compound
 ○ Not integrated due to poor chromatography
• Parent compound may be lost from the sample matrix, due to insolubility, vola-
tility, or adsorption losses
• Inaccurate quantification due to differences in response factors
2.19 Detector wavelengths
After separation of all impurities and degradation products, absorption spectra 
of all the compounds are recorded and compared by taking overlay spectra of all 
known impurities along with the main analyte in each stress condition and final-
izing a wavelength where all impurities are detected and quantified and have the 
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maximum absorbance. In case this is not feasible, select different wavelengths to 
estimate all impurities. It is also recommended to extract the chromatograms at 
lower wavelengths like 210 nm–220 nm to see if there is any additional impurities 
found, which are found to be missing at higher wavelengths; this is likely the case 
when parent compound breaks into two parts during forced degradation study with 
one part highly UV active and second part an alkyl chain where alkyl chain will 
have poor UV character.
2.20 Stability of analytical solutions
The stability of analytical solutions (sample or standard) can be established on 
auto-injector for at least 12 hours continuously in a sequence mode to know the sta-
bility of all components and ruggedness of the method (peak shapes, column back 
pressure over the period of time). To get better results, choose a diluent in which a 
test solution is stable for at least 12 hours. If the solution is found to be unstable by 
its nature, then incorporate the stability of solution in test method.
2.21 System suitability
System suitability tests verify and ensure whether the system’s performance is 
acceptable at the time of analysis in accordance with the criteria set forth in the 
procedure or not. System suitability parameters are chosen based on the criticality 
of separation. In general, resolution factor for the two adjacent peaks or closely 
eluting peaks is selected as a system suitability requirement. If the separation of 
impurities from each other and from API peak is found to be satisfactory, there 
is no need to keep a resolution factor as a system suitability parameter. In such a 
case, only a diluted standard reproducibility can be adopted as a system suitability 
requirement. Before finalizing the system suitability parameters, the separation 
needs to be studied during the robustness study to understand its behavior during 
the various deliberate changes in method.
System suitability checking must be performed on two different make of HPLC 
systems whenever the separation of any impurities is critical. For in-process-related 
impurity issues, the quantification limit (QL) concentration is to be injected, and 
signal to noise ratio (S/N) must be kept as a system suitability parameter.
2.22 Robustness of the method
Robustness by definition means the reliability of an analysis with respect to 
deliberate variations in method parameters. After finalizing all chromatographic 
conditions, robustness study with regard to mobile phase composition (±10%), pH 
(±0.2), gradient (±0.2%/min), flow rate (±0.2 mL/min), and temperature (±5°C) 
can be carried out to ensure that the developed method is stability-indicating. If the 
method of analysis is in a gradient mode, it needs to be checked on two different 
brands of HPLC or different HPLC to check the effect of the system volumes on 
separations.
2.23 Relative response factor
The relative response factor is used to correct the difference in the detector 
response of impurities with respect to the main analyte peak. It is mainly used to 
control the impurities or degradation products in a drug substance or drug product. 
RRF is established for all the known impurities using any of the slope methods. The 
standard solutions of API and all impurity can be prepared in at least five different 
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concentrations in the range of 0.1–1.0% (e.g., 0.1, 0.3, 0.5, 0.7, and 1.0%) and 
analyzed using the liquid chromatography. RRF is calculated by using the slope of 
the respective impurity and slope of the main drug (API) [38, 39].
2.24 Quantification methods
The following methods can be used for the quantitative determination of assay 
and organic impurities [40, 41]:
a. External standard method: This method is used for the assay and impurity 
estimation in a given sample, where the impurities are estimated using the 
respective impurity standard and without the API standard peak. It’s possible 
to estimate the concentration from calibration curve.
b. Area normalization: If the RRF value of known impurity is close to the API 
(analyte), i.e., 0.9–1.1, the area normalization method is chosen for quan-
tification. The recovery needs to be established without using the response 
factors.
c. Diluted standard method: If the RRF values of impurities are different from the 
analyte, the diluted standard method can be chosen.
d. Internal standard method: If the sample preparation procedure involves dif-
ferent extraction steps to avoid the error in the extraction procedure, internal 
standard procedure shall be chosen (normally for derivatization techniques 
and bioanalytical methods).
3. Conclusion
Principles involved in chromatography method development, especially for the 
analytical method development for the separation, identification, purification, and 
quantitative estimation of organic compounds using the liquid chromatography 
techniques (HPLC, UPLC, LC–MS, preparative HPLC, etc.), were emphasized in 
this chapter. Though many different types of chromatography techniques are cur-
rently in use, the liquid chromatographic methods HPLC, UPLC, and LC–MS are 
most widely utilized for the separation and quantitative determination of organic 
compounds. This chapter mainly focused on and explained the major and critical 
parameters of the liquid chromatography for the method development and optimi-
zation of a suitable stability-indicating LC method and impurity profiling studies. 
Each and every parameter which controls the purification of most of the organic 
compounds inclusive of drug, its precursors, and degraded products has been 
explained in detail in this chapter. The information given in this chapter will help 
the reader in choosing the right conditions for a particular compound to quantita-
tively separate from the reaction mixture or drug composition.
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